Birdwatch Note
2024-09-19 08:58:27 UTC - NOT_MISLEADING
The author explains further in the thread that she had to undertake vaccinations to get treatment for her genetic disease. Her condition is due to a rare (and recognized) adverse effect of these vaccinations. Notes saying misleading all misrepresent their sources by omission.
Written by 90E865A43686F47AD16440F05E1E6155ACC20EE815BA7F51C796E15CE46372A6
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1836436411613909078
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1836691313552494990
- noteId - 1836691313552494990
- participantId -
- noteAuthorParticipantId - 90E865A43686F47AD16440F05E1E6155ACC20EE815BA7F51C796E15CE46372A6 Participant Details
- createdAtMillis - 1726736307883
- tweetId - 1836436411613909078
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 0
- summary
- The author explains further in the thread that she had to undertake vaccinations to get treatment for her genetic disease. Her condition is due to a rare (and recognized) adverse effect of these vaccinations. Notes saying misleading all misrepresent their sources by omission.
Note Ratings
rated at | rated by | |
2024-09-28 13:54:21 -0500 | Rating Details | |
2024-09-21 12:31:55 -0500 | Rating Details | |
2024-09-21 11:16:59 -0500 | Rating Details | |
2024-09-21 10:11:26 -0500 | Rating Details | |
2024-09-21 08:20:42 -0500 | Rating Details | |
2024-09-21 05:16:56 -0500 | Rating Details | |
2024-09-21 04:05:21 -0500 | Rating Details | |
2024-09-20 23:23:48 -0500 | Rating Details | |
2024-09-20 12:27:03 -0500 | Rating Details | |
2024-09-20 11:06:34 -0500 | Rating Details | |
2024-09-20 09:40:38 -0500 | Rating Details | |
2024-09-20 09:05:44 -0500 | Rating Details | |
2024-09-20 07:36:12 -0500 | Rating Details | |
2024-09-20 06:11:48 -0500 | Rating Details | |
2024-09-20 06:06:44 -0500 | Rating Details | |
2024-09-20 04:43:31 -0500 | Rating Details | |
2024-09-20 04:08:52 -0500 | Rating Details | |
2024-09-20 02:26:34 -0500 | Rating Details | |
2024-09-20 02:00:25 -0500 | Rating Details | |
2024-09-20 01:47:36 -0500 | Rating Details | |
2024-09-20 00:19:07 -0500 | Rating Details | |
2024-09-19 21:05:31 -0500 | Rating Details | |
2024-09-19 19:43:19 -0500 | Rating Details | |
2024-09-19 19:12:25 -0500 | Rating Details | |
2024-09-19 19:00:16 -0500 | Rating Details | |
2024-09-19 18:49:54 -0500 | Rating Details | |
2024-09-19 18:10:05 -0500 | Rating Details | |
2024-09-19 17:01:03 -0500 | Rating Details | |
2024-09-19 15:46:45 -0500 | Rating Details | |
2024-09-19 15:28:25 -0500 | Rating Details | |
2024-09-19 15:23:59 -0500 | Rating Details | |
2024-09-19 15:11:55 -0500 | Rating Details | |
2024-09-19 15:10:49 -0500 | Rating Details | |
2024-09-19 14:50:19 -0500 | Rating Details | |
2024-09-19 13:32:32 -0500 | Rating Details | |
2024-09-19 13:27:24 -0500 | Rating Details | |
2024-09-19 10:46:29 -0500 | Rating Details | |
2024-09-19 10:17:06 -0500 | Rating Details | |
2024-09-19 08:20:53 -0500 | Rating Details | |
2024-09-19 07:30:14 -0500 | Rating Details | |
2024-09-19 05:57:56 -0500 | Rating Details | |
2024-09-19 04:38:52 -0500 | Rating Details | |
2024-09-19 04:14:55 -0500 | Rating Details | |
2024-10-21 23:03:34 -0500 | Rating Details | |
2024-10-21 16:56:05 -0500 | Rating Details | |
2024-10-21 21:52:30 -0500 | Rating Details | |
2024-10-12 14:39:54 -0500 | Rating Details |